# Vesiculobullous Disorders for NEET PG Dermatology: Pemphigus, Bullous Pemphigoid, Nikolsky Sign, Immunofluorescence, Dermatitis Herpetiformis

Source: https://tracknation.in/story/vesiculobullous-disorders-for-neet-pg-dermatology-pemphigus-bullous-pemphigoid-nikolsky-sign-immunofluorescence-dermatitis-herpetiformis (TrackNation — free UPSC notes with PYQs)

> NEET PG Dermatology: the bedside approach to blisters, pemphigus vulgaris and foliaceus, bullous pemphigoid, dermatitis herpetiformis and childhood bullous disease, with target antigens, Nikolsky sign, immunofluorescence patterns and the ICMR treatment plans, with a diagram, hooks, vignette MCQs and cards.

## Start Here

🎯 **Exam priority: High.** *Expect: flaccid vs tense blisters, the level of split, desmoglein 3 vs 1, BP180/BP230, Nikolsky and
Asboe-Hansen signs, immunofluorescence patterns (cell-surface, linear, granular), oral lesions in pemphigus, drug-induced pemphigus and pemphigoid,
dermatitis herpetiformis with coeliac disease and dapsone, and ICMR treatment by body surface area.*

CBME mapping: **DR 13.1–13.2**. Coeliac disease is also in Medicine; dapsone in Pharmacology.

*Pemphigus vulgaris, bullous pemphigoid and dermatitis herpetiformis compared; ICMR treatment; work-up. Drawn by TrackNation.*

## Approach to a Blistering Patient (ICMR)

- Look at the blister: **flaccid** blisters and erosions ± crusts on skin and mucosa → pemphigus group (adults). **Tense**
blisters with clear or haemorrhagic fluid on an itchy, red or urticarial base, healing with hypopigmentation → subepidermal disease; bullous
pemphigoid is the commonest.

- A child under 5 with erosions ringed by tense blisters on an urticarial base, on the face or around the genitals → **chronic bullous
disease of childhood** (linear IgA disease).

- Tests: Tzanck smear; biopsy from the margin of a lesion for histology; **perilesional** biopsy for direct immunofluorescence.

- Differentials: bullous impetigo, varicella, SJS/TEN, epidermolysis bullosa (infancy, pressure sites, scarring, teeth and nail changes);
congenital syphilis in a neonate — VDRL for mother and child.

- **Red flags**: fever with chills and rigors, hypotension (fluid loss or sepsis), altered sensorium. Care: monitor vitals, fluids and
electrolytes, cultures, clean non-adherent dressings, dilute potassium permanganate soaks, chlorhexidine mouthwash, soft diet. **Do not deroof
blisters** — the roof is a natural dressing; aspirate large ones with an 18G needle.

| **Disease**

 | **Target**

 | **Direct immunofluorescence (MSD)**

 | **Clue**

 |
| Pemphigus vulgaris

 | Desmoglein 3 (± 1), IgG

 | IgG on keratinocyte cell surface

 | Oral erosions first; Nikolsky +

 |
| Pemphigus foliaceus

 | Desmoglein 1, IgG

 | IgG on keratinocyte cell surface

 | Superficial crusted erosions; mucosa spared

 |
| Bullous pemphigoid

 | BP180, BP230, IgG

 | Linear IgG and C3 along basement membrane zone

 | > 60 y; tense itchy bullae; Nikolsky −

 |
| Dermatitis herpetiformis

 | Gluten-related, IgA

 | Granular IgA in dermal papillary tips

 | Elbows, knees, buttocks; coeliac

 |

## Pemphigus

- **Pemphigus vulgaris**: middle-aged adults; IgG against **desmoglein 3** (± 1) → acantholysis and
**intraepidermal** blisters. About half have only oral erosions, and oral lesions often come before skin lesions (painful mouth, poor
intake). **Nikolsky** (epidermis shears with sideways pressure) and **Asboe-Hansen** (pressure spreads the bulla) signs
are positive. Untreated, it is often fatal within 5 years. Variants: pemphigus vegetans (folds), paraneoplastic pemphigus.

- **Pemphigus foliaceus**: IgG against **desmoglein 1**, superficial split, crusted erosions, mucosa rarely involved;
drugs — penicillamine, nifedipine, captopril; endemic form fogo selvagem; pemphigus erythematosus on the cheeks.

- **ICMR treatment** (only where monitoring exists): mucosal or < 5% BSA — prednisolone 0.5 mg/kg/day with azathioprine,
mycophenolate, cyclophosphamide, methotrexate or dapsone; > 5% BSA — stabilise and refer; tertiary — dexamethasone–cyclophosphamide pulse or
**rituximab** (MSD lists rituximab as first line).

## Bullous Pemphigoid and Dermatitis Herpetiformis

- **Bullous pemphigoid**: commonest autoimmune blistering disease, mostly over 60. IgG against hemidesmosomal **BP180 and
BP230** → complement → **subepidermal** blister (lamina lucida) rich in eosinophils. Itchy urticarial plaques, then
**tense** bullae on trunk and flexures; mucosa rarely; Nikolsky negative; DIF — **linear IgG and C3** along the basement
membrane zone. Drug triggers include DPP-4 inhibitors (gliptins) and PD-1 inhibitors.

- ICMR: limited (< 10% BSA) — topical clobetasol up to 30 g/day ± prednisolone 0.5 mg/kg/day ± dapsone, doxycycline, niacinamide or
immunosuppressants; extensive (> 10%) — prednisolone 0.75–1 mg/kg/day at tertiary level.

- **Dermatitis herpetiformis**: intensely itchy papulovesicles on extensor elbows and knees, sacrum, buttocks and occiput; nearly all
have (often silent) **coeliac disease**; DIF — **granular IgA in dermal papillary tips**; tTG and endomysial IgA support it.
Treat with **dapsone** (test G6PD first; haemolysis, methaemoglobinaemia) and a strict gluten-free diet, which can later stand alone. Risk
of small-bowel lymphoma.

## Traps the Examiner Sets

- Mouth ulcers before skin blisters in a middle-aged adult → pemphigus vulgaris.

- Elderly, itchy, tense blisters, Nikolsky negative → bullous pemphigoid.

- Linear IgG = pemphigoid; granular IgA in papillae = dermatitis herpetiformis.

- Never deroof blisters; check G6PD before dapsone.

## Memory Hooks & Shortcuts

*Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.*

- 🧠 **'Vulgaris = mouth first (Dsg3); Foliaceus = superficial Flakes, mouth Free (Dsg1)'** — pemphigus types

- 🧠 **'Pemphigoid = Pensioners, Pruritus, Pressure-tense blisters'** — bullous pemphigoid

- 🧠 **Immunofluorescence: 'Pemphigus Paints cell surfaces; Pemphigoid Pencils a Line; DH Dots the papillae'** — DIF patterns

- 🧠 **DH = 'Dapsone + Diet (gluten-free)'** — dermatitis herpetiformis

- 🧠 **Blister roof = 'nature's dressing — never deroof'** — care

## Rapid-Revision Cards

- Pemphigus group.

- Subepidermal; pemphigoid commonest.

- Desmoglein 3 (± 1).

- Desmoglein 1; mucosa spared.

- Oral erosions.

- Epidermis shears: PV +, BP −.

- Bulla spreads on pressure.

- IgG on keratinocyte surface.

- Penicillamine, captopril, nifedipine.

- > 60 years.

- BP180, BP230.

- Linear IgG + C3 at BMZ.

- DPP-4 inhibitors.

- Clobetasol ≤ 30 g/day.

- Coeliac; elbows, knees, buttocks.

- Granular IgA, papillary tips.

- Dapsone + gluten-free diet.

- G6PD first; methaemoglobinaemia.

- Chronic bullous disease of childhood.

- Perilesional skin.

- Don't deroof; aspirate 18G.

## Sources

*Facts in this article were checked against these documents.*

- Standard Treatment Workflow: Immunobullous Dermatoses — Indian Council of Medical Research, DHR, 2022 (link)

- MSD Manual Professional: Pemphigus Vulgaris; Pemphigus Foliaceus; Bullous Pemphigoid; Dermatitis Herpetiformis — Merck & Co. (MSD Manuals), reviewed 2024–26 (link)

- Competency Based Undergraduate Curriculum, Dermatology (DR 13) — National Medical Commission, 2024

## Test Yourself: Practice Questions

Thirty questions in NEET PG style, most of them clinical vignettes.

## Practice Questions (NEET PG pattern)

*Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer
was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.*

**Q1.** A middle-aged adult has painful oral erosions for months, followed by flaccid blisters and raw erosions on the trunk. The most likely diagnosis is

- (a) bullous pemphigoid

- (b) dermatitis herpetiformis

- (c) pemphigus foliaceus

- (d) pemphigus vulgaris

**Answer: (d)** — Oral lesions often precede skin.

**Q2.** The main target antigen in pemphigus vulgaris is

- (a) type VII collagen

- (b) tissue transglutaminase

- (c) desmoglein 3

- (d) BP180

**Answer: (c)** — Sometimes also desmoglein 1.

**Q3.** Loss of adhesion between keratinocytes producing an intraepidermal blister is called

- (a) spongiosis

- (b) parakeratosis

- (c) hyperkeratosis

- (d) acantholysis

**Answer: (d)** — The mechanism of pemphigus.

**Q4.** Rubbing apparently normal skin next to a blister makes the upper epidermis slide off. This sign is

- (a) Darier sign

- (b) Nikolsky sign

- (c) Koebner phenomenon

- (d) Auspitz sign

**Answer: (b)** — Positive in pemphigus vulgaris.

**Q5.** Gentle pressure on an intact bulla makes the fluid spread under the adjacent skin. This is the

- (a) Asboe-Hansen sign

- (b) Auspitz sign

- (c) Darier sign

- (d) Nikolsky sign

**Answer: (a)** — Also reflects poor epidermal cohesion.

**Q6.** Direct immunofluorescence in pemphigus vulgaris shows

- (a) IgG on the keratinocyte cell surface (intercellular)

- (b) linear IgG along the basement membrane

- (c) granular IgA in papillary tips

- (d) no deposits

**Answer: (a)** — Cell-surface (intercellular) pattern.

**Q7.** Without treatment, pemphigus vulgaris

- (a) is harmless

- (b) is often fatal, usually within 5 years

- (c) always resolves in weeks

- (d) only scars

**Answer: (b)** — Steroids and immunosuppressants improved prognosis.

**Q8.** A patient develops superficial skin erosions without mouth lesions after starting captopril. The likely diagnosis and antigen are

- (a) dermatitis herpetiformis — IgA

- (b) bullous pemphigoid — BP180

- (c) pemphigus foliaceus — desmoglein 1

- (d) pemphigus vulgaris — desmoglein 3

**Answer: (c)** — Also penicillamine, nifedipine.

**Q9.** An endemic form of pemphigus foliaceus seen in children and young adults in South America is

- (a) fogo selvagem

- (b) pemphigus vegetans

- (c) Hailey–Hailey disease

- (d) paraneoplastic pemphigus

**Answer: (a)** — Endemic PF.

**Q10.** ICMR first-line treatment for mucosal or limited (< 5% BSA) pemphigus is

- (a) dapsone alone at home without monitoring

- (b) antibiotics only

- (c) topical steroid only

- (d) oral prednisolone 0.5 mg/kg/day with an adjuvant such as azathioprine

**Answer: (d)** — Only where monitoring is available.

**Q11.** Extensive pemphigus at a tertiary centre may be treated with

- (a) antihistamines

- (b) topical clobetasol alone

- (c) dexamethasone–cyclophosphamide pulse therapy or rituximab

- (d) gluten-free diet

**Answer: (c)** — ICMR tertiary options.

**Q12.** An 80-year-old has itchy urticarial plaques followed by large tense blisters on the trunk and flexures; Nikolsky sign is negative and the mouth is spared. The diagnosis is

- (a) pemphigus vulgaris

- (b) SJS

- (c) pemphigus foliaceus

- (d) bullous pemphigoid

**Answer: (d)** — Most common autoimmune blistering disease.

**Q13.** The antigens targeted in bullous pemphigoid are

- (a) tissue transglutaminase

- (b) desmoglein 1 and 3

- (c) type VII collagen

- (d) BP180 and BP230 (hemidesmosomal)

**Answer: (d)** — Complement-activating IgG.

**Q14.** The level of split in bullous pemphigoid is

- (a) subcorneal

- (b) within the dermis

- (c) subepidermal (lamina lucida)

- (d) suprabasal intraepidermal

**Answer: (c)** — Hence tense blisters.

**Q15.** Direct immunofluorescence in bullous pemphigoid shows

- (a) intercellular IgG

- (b) IgM in vessels

- (c) linear IgG and C3 along the basement membrane zone

- (d) granular IgA in papillary tips

**Answer: (c)** — Linear pattern.

**Q16.** A diabetic patient develops bullous pemphigoid after starting a new oral antidiabetic drug. The likely culprit class is

- (a) alpha-glucosidase inhibitors

- (b) DPP-4 inhibitors (gliptins)

- (c) biguanides

- (d) sulfonylureas

**Answer: (b)** — Drug-induced pemphigoid.

**Q17.** ICMR treatment for limited bullous pemphigoid (< 10% BSA) begins with

- (a) cyclophosphamide pulse

- (b) rituximab

- (c) gluten-free diet

- (d) topical clobetasol propionate up to 30 g/day

**Answer: (d)** — ± prednisolone 0.5 mg/kg, dapsone, doxycycline, niacinamide.

**Q18.** For extensive bullous pemphigoid (> 10% BSA), ICMR advises

- (a) prednisolone 0.75–1 mg/kg/day at tertiary level

- (b) no treatment

- (c) antibiotics alone

- (d) topical steroid only at home

**Answer: (a)** — With steroid-sparing agents.

**Q19.** Doxycycline with niacinamide is an ICMR option in

- (a) epidermolysis bullosa

- (b) dermatitis herpetiformis

- (c) bullous pemphigoid

- (d) pemphigus vulgaris

**Answer: (c)** — Anti-inflammatory regimen.

**Q20.** A patient has intensely itchy papulovesicles on the elbows, knees and buttocks. The disease is strongly associated with

- (a) diabetes

- (b) coeliac disease

- (c) hepatitis C

- (d) HIV

**Answer: (b)** — Dermatitis herpetiformis.

**Q21.** Direct immunofluorescence in dermatitis herpetiformis shows

- (a) granular IgA in the dermal papillary tips

- (b) linear IgA

- (c) linear IgG along the BMZ

- (d) intercellular IgG

**Answer: (a)** — Linear IgA = linear IgA disease.

**Q22.** The drug that rapidly controls the itch of dermatitis herpetiformis is

- (a) methotrexate

- (b) cyclosporine

- (c) prednisolone

- (d) dapsone

**Answer: (d)** — Plus a gluten-free diet.

**Q23.** Before starting dapsone, which test is needed to reduce the risk of haemolysis?

- (a) thyroid function

- (b) serum IgA

- (c) G6PD level

- (d) HLA-B*15:02

**Answer: (c)** — Haemolysis risk is higher in G6PD deficiency.

**Q24.** A common adverse effect of dapsone is

- (a) hyperkalaemia

- (b) methaemoglobinaemia

- (c) hirsutism

- (d) gingival hyperplasia

**Answer: (b)** — Also haemolysis, agranulocytosis, dapsone syndrome.

**Q25.** Long-term control of dermatitis herpetiformis without drugs is possible with

- (a) sun avoidance

- (b) a strict gluten-free diet

- (c) topical steroids

- (d) antihistamines

**Answer: (b)** — Drug may be stopped later.

**Q26.** A 3-year-old has erosions surrounded by a ring of tense blisters on an urticarial base around the genitals and face. The likely diagnosis is

- (a) bullous impetigo only

- (b) chronic bullous disease of childhood

- (c) epidermolysis bullosa

- (d) pemphigus vulgaris

**Answer: (b)** — Linear IgA disease of childhood.

**Q27.** For direct immunofluorescence, the biopsy should be taken from

- (a) the centre of an old erosion

- (b) distant normal skin of the back

- (c) the blister roof only

- (d) perilesional skin

**Answer: (d)** — Histology from the lesion margin.

**Q28.** ICMR advice on intact large blisters is to

- (a) deroof all blisters

- (b) apply potent steroid under occlusion

- (c) excise them

- (d) avoid deroofing; aspirate with an 18G needle if needed

**Answer: (d)** — The roof is a natural dressing.

**Q29.** A patient with extensive pemphigus develops fever with rigors, hypotension and confusion. These red flags indicate

- (a) steroid response

- (b) drug allergy only

- (c) fluid loss or sepsis needing urgent care

- (d) a normal course

**Answer: (c)** — ICMR red flag signs.

**Q30.** A neonate is born with blisters and erosions. Besides epidermolysis bullosa, ICMR asks you to consider

- (a) bullous pemphigoid

- (b) congenital syphilis — VDRL for mother and child

- (c) pemphigus foliaceus

- (d) dermatitis herpetiformis

**Answer: (b)** — Bullous lesions in neonates.

### Active Recall

From memory: contrast pemphigus vulgaris, pemphigus foliaceus, bullous pemphigoid and dermatitis herpetiformis by antigen, split, blister, mucosa, Nikolsky sign and immunofluorescence, and give the ICMR treatment and general blister care.
